Cite
HARVARD Citation
Caro, L. et al. (2020). Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumonia. Journal of antimicrobial chemotherapy. pp. 1546-1553. [Online].